Receptor Mediated Delivery Systems for Cancer Therapeutics-Reference-Cited by-同舟云学术

Receptor Mediated Delivery Systems for Cancer Therapeutics

Published:2011-09-27 Issue: Volume: Page:329-355
ISSN:
Container-title:Fundamentals and Applications of Controlled Release Drug Delivery
language:
Short-container-title:

Author:

Minko Tamara

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4614-0881-9_12.pdf

Reference97 articles.

1. Ehrlich P (1906) Studies in immunity. Plenium Press, New York

2. Minko T, Dharap SS, Pakunlu RI, Wang Y (2004) Molecular targeting of drug delivery systems to cancer. Curr Drug Targets 5(4):389–406

3. Vyas SP, Singh A, Sihorkar V (2001) Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit Rev Ther Drug Carrier Syst 18(1):1–76

4. Minko T (2004) Drug targeting to the colon with lectins and neoglycoconjugates. Adv Drug Deliv Rev 56(4):491–509

5. De Paoli P (2008) Novel virally targeted therapies of EBV-associated tumors. Curr Cancer Drug Targets 8(7):591–596

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations;Pharmaceutics;2021-07-11

2. Metastatic and triple-negative breast cancer: challenges and treatment options;Drug Delivery and Translational Research;2018-07-05

3. Recent Advances in Drug Delivery of Polymeric Nano-Micelles;Current Drug Metabolism;2017-01-19

4. Selective DNA Delivery to Tumor Cells Using an Oligoarginine-LTVSPWY Peptide;PLoS ONE;2014-10-22

5. Galactosylated poly(ethylene glycol) methacrylate-st-3-guanidinopropyl methacrylamide copolymers as siRNA carriers for inhibiting Survivin expressionin vitroandin vivo;Journal of Drug Targeting;2014-01-09